- Home
- IRMD vs GRAL Comparison
IRMD vs GRAL Comparison
Compare IRMD & GRAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRMD
- GRAL
- Stock Information
- Founded
- IRMD 1992
- GRAL 2016
- Country
- IRMD United States
- GRAL United States
- Employees
- IRMD N/A
- GRAL N/A
- Industry
- IRMD Medical/Dental Instruments
- GRAL
- Sector
- IRMD Health Care
- GRAL
- Exchange
- IRMD Nasdaq
- GRAL NYSE
- Market Cap
- IRMD 737.7M
- GRAL 610.9M
- IPO Year
- IRMD 2014
- GRAL N/A
- Fundamental
- Price
- IRMD $59.17
- GRAL $17.42
- Analyst Decision
- IRMD Strong Buy
- GRAL Hold
- Analyst Count
- IRMD 1
- GRAL 2
- Target Price
- IRMD $60.00
- GRAL $16.00
- AVG Volume (30 Days)
- IRMD 40.7K
- GRAL 967.8K
- Earning Date
- IRMD 02-06-2025
- GRAL 02-15-2025
- Dividend Yield
- IRMD 1.01%
- GRAL N/A
- EPS Growth
- IRMD 13.16
- GRAL N/A
- EPS
- IRMD 1.46
- GRAL N/A
- Revenue
- IRMD $71,305,130.00
- GRAL $117,669,000.00
- Revenue This Year
- IRMD $13.29
- GRAL $32.48
- Revenue Next Year
- IRMD $10.76
- GRAL $14.72
- P/E Ratio
- IRMD $40.53
- GRAL N/A
- Revenue Growth
- IRMD 13.23
- GRAL 111.83
- 52 Week Low
- IRMD $40.18
- GRAL $12.33
- 52 Week High
- IRMD $59.31
- GRAL $24.92
- Technical
- Relative Strength Index (RSI)
- IRMD 67.63
- GRAL N/A
- Support Level
- IRMD $55.36
- GRAL N/A
- Resistance Level
- IRMD $59.31
- GRAL N/A
- Average True Range (ATR)
- IRMD 1.65
- GRAL 0.00
- MACD
- IRMD 0.30
- GRAL 0.00
- Stochastic Oscillator
- IRMD 97.69
- GRAL 0.00
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
About GRAL GRAIL INC
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages.